Trial Profile
Multidisciplinary team approach in management of Regorafenib toxicities for patients with metastatic colorectal cancer: Multi-institutional joint research in Shizuoka
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2013
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms T-ReX
- 21 Jun 2013 New trial record